Federal Court Overturns Gilead Sciences and Merck Patent Dispute
Federal court judge orders Merck to repay $2.5 Billion to Gilead in overturned patent decision. Source: BioSpace
Federal court judge orders Merck to repay $2.5 Billion to Gilead in overturned patent decision. Source: BioSpace
AbbVie and Voyager Therapeutics inked a collaboration deal to develop treatments for Alzheimer’s disease and other neurodegenerative diseases. Source: BioSpace
Life sciences giant Johnson & Johnson may be shopping around its sterilization products division. Source: BioSpace
Nevada-based PDL BioPharma, Inc. said it will no longer pursue a proposed acquisition of Neos Therapeutics. Source: BioSpace
AbbVie today presented new positive results from a Phase 2b dose-ranging study evaluating upadacitinib, an investigational, once-daily oral JAK1-selective inhibitor, in adult patients with moderate to severe atopic dermatitis. Source:…
RELIEF™ trial demonstrated statistically significant reductions in oral ulcers with apremilast 30 mg versus placebo through week 12. Source: BioSpace
AbbVie presented today new positive results from the pivotal Phase 3 ultIMMa-1 and ultIMMa-2 replicate clinical trials that evaluated the safety and efficacy of risankizumab (150 mg) compared to placebo…
If you had a crystal ball, you probably would have invested in Berkshire Hathaway in 1964, or Apple in the 1980s. Source: BioSpace
Government officials say they are now certain they know who launched the NotPetya cyberwar that slammed operations at Merck last year. Source: BioSpace
Shares of Pacira plunged more than 15 percent this morning after the company revealed the FDA panel's decision. Source: BioSpace